Integrated 18F-FDG PET/CT in the staging of patients with suspected primary ovarian cancer.

Completed

• Conditions: ovarian cancer; ovarian neoplasm; 10033283

• Registration Number: NL-OMON29961
• Lead Sponsor: Academisch Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

age > 18 years and suspicion of primary ovarian cancer based on the results of complaints, physical examination and findings from ultrasound

Exclusion Criteria

pregnancy, unwillingness to give informed medical consent, evidence of significant psychiatric disorder by history or exam, previous pelvic-abdominal surgery, radiotherapy within six months of study entry or chemotherapy.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome measure is the difference in ovarian carcinoma stage<br /><br>according to the International Federation of Gynecology and Obstetrics (FIGO),<br /><br>based on PET/CT and surgery/histological findings. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>niet van toepassing</p><br>